CV Sciences (CVSI) Financials

Start with the income statement to understand CVSI's revenue, cost of goods sold, and profitability. The balance sheet shows assets, liabilities, and shareholder equity at a point in time. The cash flow statement reveals how much cash the business generates from operations, investing, and financing activities. For cannabis companies, pay special attention to cash burn rate and debt levels, as limited access to traditional banking makes cash management critical.

Key metrics for evaluating CV Sciences include: revenue growth (is the company expanding?), gross margin (how efficiently does it produce?), operating cash flow (does the core business generate cash?), debt-to-equity ratio (how leveraged is it?), and cash runway (how long can it operate at current burn rate?). For cannabis companies specifically, also watch for the impact of IRS Section 280E on effective tax rates and adjusted EBITDA as a proxy for operational profitability.

TTM stands for "trailing twelve months" and represents the total revenue CV Sciences has generated over the most recent four quarters combined. TTM revenue is useful because it smooths out seasonal variations and provides a more complete picture than any single quarter. It's the standard timeframe used for valuation ratios like price-to-sales (P/S), which compares the stock's market cap to its TTM revenue.

Look at multiple profitability metrics: gross margin shows production efficiency, operating margin reflects the core business profitability, and net margin accounts for all expenses including taxes. For cannabis companies like CV Sciences, GAAP profitability can be distorted by non-cash charges (impairments, stock-based compensation) and Section 280E tax burdens. Many investors use adjusted EBITDA to get a clearer picture of operational performance. Compare margins to industry peers for context.

The price-to-sales (P/S) ratio divides a company's market capitalization by its trailing twelve months of revenue. Since many cannabis companies are not yet profitable, the P/S ratio is one of the most widely used valuation metrics in the sector. A lower P/S ratio may indicate a stock is undervalued relative to its revenue, while a higher ratio suggests investors are paying a premium for growth expectations. Compare CVSI's P/S to other cannabis companies for meaningful context.

Compare CV Sciences against cannabis peers using metrics like price-to-sales ratio, enterprise value-to-revenue, and price-to-book. Since many cannabis companies aren't profitable, traditional P/E ratios are less useful. Also compare growth rates, gross margins, and cash positions. Make sure to compare within the same sub-sector (MSOs vs. LPs vs. ancillary companies) for the most meaningful comparisons, as different business models have different typical valuation ranges.

Quarterly (10-Q) filings report three months of financial data and are released four times per year. Annual (10-K) filings provide a comprehensive twelve-month overview with more detailed disclosures, audited financials, and management discussion. Both are filed with the SEC. Quarterly data is useful for tracking short-term trends and seasonal patterns, while annual data gives a broader view. Cannabis companies often show significant quarter-to-quarter variation due to harvest cycles and state-by-state rollouts.